New digital tool aims to tackle stigma in HIV care
NCT ID NCT07370298
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new digital tool called INCLUDE, designed to help clinics in Nepal identify and reduce stigma faced by people living with HIV. The tool includes a stigma assessment, a dashboard linking stigma to care data, and a library of stigma-reduction activities. Researchers will check if the tool is acceptable and feasible for use in four ART centers, involving 88 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
INCLUDE digital health tool (behavioral intervention)
What this could lead to
If successful, this tool could help clinics identify and address stigma, potentially improving HIV care and reducing loss to follow-up in Nepal and similar settings.
What could go wrong
This is a small pilot study with only 88 participants, testing feasibility and acceptability, not effectiveness. The tool may not work in other contexts or may not lead to better health outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Possible
Kathmandu, Bagmati, Nepal